HIV Archives | Be Korea-savvy
Health Authorities Publish Guidelines on HIV Treatment

Health Authorities Publish Guidelines on HIV Treatment

SEOUL, Dec. 4 (Korea Bizwire) — The Korea Disease Control and Prevention Agency announced Thursday that new guidelines on treating human immunodeficiency virus (HIV) patients have been published. The guide includes eight recommendations for the healthcare workers, caretakers, and other related personnel. On the patient’s right to health, the guide proclaims that all patients have [...]

HIV Prevention Trials Network Awarded U.S. National Institutes of Health Funding to Continue Research Agenda

HIV Prevention Trials Network Awarded U.S. National Institutes of Health Funding to Continue Research Agenda

DURHAM, N.C., Nov. 30 (Korea Bizwire) — Drs. Myron S. Cohen and Wafaa M. El-Sadr, principal investigators of the HIV Prevention Trials Network (HPTN), in collaboration with FHI 360, have received a seven-year award from the U.S. National Institutes of Health as part of the next funding cycle (2020-2027) for the Network. The core and [...]

HPTN 084 Study Demonstrates Superiority of CAB LA to Oral FTC/TDF for the Prevention of HIV

HPTN 084 Study Demonstrates Superiority of CAB LA to Oral FTC/TDF for the Prevention of HIV

Durham, N.C., Nov. 9 (Korea Bizwire) — Researchers from the HIV Prevention Trials Network (HPTN) announced today data from the HPTN 084 clinical trial indicate that a pre-exposure prophylaxis (PrEP) regimen of long-acting cabotegravir (CAB LA) injections once every eight weeks was safe and superior to daily oral tenofovir/emtricitabine (FTC/TDF) for HIV prevention among cisgender women in sub-Saharan Africa. During a planned review of study data, an independent Data and Safety Monitoring Board (DSMB) recommended the study sponsor―the National Institute of Allergy and Infectious Diseases [...]

Same-sex Sexual Contact Primary Driver of HIV Infections in S. Korea

Same-sex Sexual Contact Primary Driver of HIV Infections in S. Korea

SEOUL, July 15 (Korea Bizwire) — The number of people who are infected with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) through same-sex sexual contact is gradually increasing in South Korea. Among those who were infected with HIV or AIDS last year through sexual contact, more than half of them were infected through [...]

Younger HIV Patients More Likely to Skip Treatment: Study

Younger HIV Patients More Likely to Skip Treatment: Study

SEOUL, Oct. 31 (Korea Bizwire) — Young HIV-infected adults tend to skip hospital visits for medical care more than elderly patients, a study said Wednesday. A research by a team from Boramae Medical Center run by Seoul National University Hospital showed that of the adults needing regular antiretroviral therapy (ART) for their human immunodeficiency virus [...]

Inovio HIV Vaccine PENNVAX®-GP Delivered Intradermally Generated Robust, Long-Term Best-In-Class Antibody and T Cell Immune Responses

Inovio HIV Vaccine PENNVAX®-GP Delivered Intradermally Generated Robust, Long-Term Best-In-Class Antibody and T Cell Immune Responses

PLYMOUTH MEETING, Pa., Oct. 25 (Korea Bizwire) — Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that its synthetic HIV vaccine PENNVAX®-GP delivered via intradermal route demonstrated durable and robust antibody and T cell immune responses measured throughout the duration of the Phase 1 clinical study. In this reported study, PENNVAX-GP plasmids were delivered intradermally or intramuscularly [...]

1,191 New HIV/AIDS Cases Reported 2017

1,191 New HIV/AIDS Cases Reported 2017

SEOUL, Aug. 11 (Korea Bizwire) — The number of new cases of Human Immunodeficiency Virus Infection and Acquired Immune Deficiency Syndrome (HIV/AIDS) totaled 1,191 in South Korea in 2017. Approximately 1 out of 3 infected individuals were in their 20s. According to data provided by the Korea Centers for Disease Control and Prevention on the [...]

Health Ministry Approves HIV Prevention Drug, but High Price Remains an Obstacle

Health Ministry Approves HIV Prevention Drug, but High Price Remains an Obstacle

SEOUL, Feb. 20 (Korea Bizwire) — The Ministry of Food and Drug Safety has approved the sale of Truvada, a type of HIV prevention drug PrEP, in South Korea, but the medicine’s high price is raising concerns over its affordability. According to sources close to the pharmaceutical industry on Monday, Gilead Sciences Korea’s HIV prevention medication [...]